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Seattle, WA; Davis, CA; Chapel Hill, NC; and Honolulu, HIBackground The incidence of atrial fibrillation (AF) is higher in non-Hispanicwhites (NHWs) comparedwith other race-ethnic
groups, despite more favorable cardiovascular risk profiles. To explore reasons for this paradox, we compared the hazards of AF from
traditional and other risk factors between 4 race-ethnic groups in a large cohort of postmenopausal women.
Methods We included 114,083 NHWs, 11,876 African Americans, 5,174 Hispanics, and 3,803 Asians from the
Women's Health Initiative free of AF at baseline. Women, averaging 63 years old, were followed up for incident AF using
hospitalization records and diagnostic codes from Medicare claims.
Results Over a mean of 13.7 years, 19,712 incident cases of AFwere recorded. Despite a higher burden of hypertension, diabetes,
and obesity, annual AF incidence was lower among nonwhites (0.7%, 0.4%, and 0.4% for African American, Hispanic, and Asian
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degree of individual risk of AF among 4 race-ethnic groups. However, major AF risk factors conferred a higher-attributable risk
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http://dx.doi.org/10.1016/j.ahj.2016.03.004per year, approximately 15% of all strokes in the
United States.3 It is associated with increased mortality
after adjustment for numerous cardiovascular risk factors
and comorbidities,4 and has been linked to increased risk
of myocardial infarction5 and sudden cardiac death.6
Women comprise 60% of individuals with AF older than
75 years, and the clinical consequences of AF for women
are substantial.7 Women with AF are at higher risk for
stroke and myocardial infarction, and have a higher
overall mortality risk than do men.3,4,8
Analyses of large prospective cohorts, including the
Framingham Heart Study,9 the Cardiovascular Health
Study10 and others,11-13 have established principal
independent risk factors of AF including age, hyperten-
sion, diabetes mellitus, obesity, myocardial infarction,
coronary heart disease, and heart failure. However, these
prior studies were conducted in primarily non-Hispanic
white (NHW) populations, potentially limiting their
generalizability to other race-ethnic groups.14
Rates of AF vary significantly between different racial
and ethnic groups.1,15 The incidence of AF is lower in
African Americans compared with NHWs in the Women's 
Health Initiative Observational Study (WHI OS),16 the 
Cardiovascular Health Care Study,10 and several other 
study cohorts, independent of socioeconomic and other 
risk factors.15,2,17,18 Hispanics and Asians also have lower 
rates of AF compared with NHWs.15,16,19
The difference in rates of AF among race-ethnic groups 
may be explained by either differences in underlying 
genetic susceptibility, differences in prevalence of risk 
factors of AF, differences in the hazards due to individual 
risk factors, or a combination of these variables. Although 
a portion of the race-ethnic difference may be explained 
by genetic ancestry in some populations,20 this was not 
the case in older women in the WHI.21 We therefore 
sought to characterize the differences in the hazards due 
to several risk predictors for AF by race and ethnicity in 
the WHI, to measure differences in the attributable risk 
(AR) due to established AF risk factors, and to validate 
existing AF predictive models in this well-characterized 
and diverse population of postmenopausal women.
Methods
Study population
In order to maximize the number of participants from 
the different race-ethnic groups, the study population 
included all NHW, African American, Hispanic, and Asian 
participants from the WHI OS and the randomized 
clinical trials (RCTs). Participants who self-identified as 
“Other” were excluded from these analyses. The 
methods of WHI recruitment and follow-up are described 
elsewhere in detail.22-24 Briefly, 93,676 postmenopausal 
women were enrolled in the WHI OS and 68,132 women 
were enrolled in at least one of the RCTs of hormone 
therapy, dietary modification, and calcium/vitamin D, 
between October 1993 and December 1998. Participants 
were recruited primarily through mass mailings and 
enrolled at 1 of 40 US clinical centers. Participants were 
postmenopausal aged between 50 and 79 years at the 
time of study enrollment. After initial study enrollment, 
participants were under continued surveillance for 
cardiovascular disease outcomes, including new-onset 
AF. The average time of follow-up was 13.7 years 
extending through 2014. Participants with AF at baseline 
(as reported on the initial questionnaire or evidenced on 
baseline electrocardiogram [ECG]) or with missing 
covariate data were excluded from these analyses.
Baseline variables
Participants completed self-administered question-
naires at study enrollment, including demographic and 
clinical characteristics at baseline. Study questionnaires, 
physical measurements, and quality assurance have 
been detailed previously.22,23 Race and ethnicity were 
self-reported in the baseline questionnaire. Participants 
underwent measurement of blood pressure, height,weight, and hip and waist circumferences at enrollment.
Body mass index (BMI) was calculated as weight (in
kilograms) divided by the square of measured height (in
meters squared). Age, income, education, history of
hypertension, diabetes, hyperlipidemia, coronary artery
disease (CAD), stroke, congestive heart failure (CHF),
peripheral artery disease (PAD), smoking, and alcohol use
were ascertained by self-report on baseline question-
naires. Participants with measured resting systolic blood
pressure ≥140 mm Hg or diastolic blood pressure ≥90
mm Hg at the initial clinic visit were also classified as
hypertensive. Physical activity was assessed using self-
reported questionnaires and frequency, intensity, duration,
and types of physical activity were evaluated as previously
described. 25,26 Standard resting 12-lead ECGs (MAC PC;
Marquette Electronics Inc, Milwaukee, WI) were recorded
in participants enrolled in the RCTs and processed using
the 2001 version of the GE Marquette 12-SL program (GE
Marquette Electronics, Inc) in a central electrocardiogra-
phy laboratory. The PR interval was determined as the
time between the onset of the p-wave and the onset of the
QRS complex.
Ascertainment of incident AF
Identification of cases of incident AF has been
described in previous studies.16,27 Participants complet-
ed annual questionnaires updating their interval medical
history. Medical records were obtained in the event of
self-reported hospitalization and the International Clas-
sification of Diseases, Ninth Revision (ICD-9) code for
AF (427.31) was extracted from these records. WHI data
were also linked with Centers for Medicare & Medicaid
Services (CMS) data using social security numbers, birth
dates, and death dates, with 97% of Medicare-eligible WHI
participants successfully linked. Among those with
Medicare coverage, incident AF was identified by the
first occurrence of ICD-9 code 427.31 in any diagnosis
position in the inpatient (MEDPAR), outpatient, and
carrier files during the years 1994 to 2012. Several
sensitivity analyses were performed with atrial flutter
(ICD-9 code 427.32).
Because CMS data were available for some participants,
but not others, at different periods over WHI follow-up, a
time-dependent indicator variable of Medicare coverage
was added to the Cox hazard models described below to
adjust for possible ascertainment bias related to differen-
tial exposure to CMS. Medicare time eligible for analysis
included those intervals where participants were en-
rolled in fee-for-service Medicare and not simultaneously
enrolled in a Medicare-managed care plan.
Statistical analysis
Baseline characteristics of participants were compared
across race-ethnic categories, using either analysis of
variance for continuous variables or the χ2 test for
categorical variables.






Age (y), mean (SD) 63.1 (7.2) 63.5 (7.1) 61.4 (7.1) 60.2 (6.7) 63.0 (7.5) b.001
Income b.001
b$20,000 19,935 14.8 14,677 12.9 3161 26.6 1671 32.3 426 11.2
$20,000-$49,999 56,471 41.9 48,440 42.5 4758 40.1 1915 37.0 1358 35.7
$50,000-$74,999 25,524 18.9 22,098 19.4 1919 16.2 637 12.3 870 22.9
≥$75,000 24,352 18.0 21,801 19.1 1203 10.1 430 8.3 918 24.1
Education b.001
≤ High school/GED 29,531 21.9 23,652 20.7 2945 24.8 2134 41.2 800 21.0
Some college 50,930 37.7 43,057 37.7 4645 39.1 1900 36.7 1328 34.9
≥College degree 54,475 40.4 47,374 41.5 4286 36.1 1140 22.0 1675 44.0
Medical history
Hypertension b.001
None/never treated 76,779 56.9 67,396 59.1 4222 35.6 3182 61.5 1979 52.0
Untreated 24,260 18.0 20,260 17.8 2280 19.2 936 18.1 784 20.6
Treated 33,897 25.1 26,427 23.2 5374 45.3 1056 20.4 1040 27.3
BMI (kg/m2), mean (SD) 27.9 (5.9) 27.6 (5.8) 31.2 (6.7) 29.0 (5.8) 24.8 (4.5) b.001
Diabetes mellitus 5652 4.2 3665 3.2 1410 11.9 358 6.9 219 5.8 b.001
Hyperlipidemia 18,437 13.7 15,063 13.2 1832 15.4 775 15.0 767 20.2 b.001
CAD 3778 2.8 3112 2.7 489 4.1 97 1.9 80 2.1 b.001
MI 2686 2.0 2201 1.9 379 3.2 62 1.2 44 1.2 b.001
CABG/PTCA 2090 1.5 1768 1.5 217 1.8 51 1.0 54 1.4 b.001
Stroke 1588 1.2 1188 1.0 280 2.4 80 1.5 40 1.1 b.001
Heart failure 795 0.6 577 0.5 172 1.4 31 0.6 15 0.4 b.001
PAD 2413 1.8 1893 1.7 374 3.1 116 2.2 30 0.8 b.001
Systolic BP (mm Hg), mean (SD) 127.1 (17.6) 126.5 (17.5) 132.1 (17.8) 125.7 (16.8) 129.8 (18.7) b.001
Diastolic BP (mm Hg), mean (SD) 75.2 (9.2) 74.8 (9.1) 78.3 (9.6) 75.1 (9.1) 78.1 (9.7) b.001
Heart rate (beats/min), mean (SD) 69.6 (12.0) 69.5 (11.9) 70.8 (13.2) 68.8 (10.4) 68.1 (10.3) b.001
Habits
Smoking b.001
Never 68,602 50.8 56,737 49.7 5867 49.4 3248 62.8 2750 72.3
Past 57,025 42.3 49,898 43.7 4666 39.3 1557 30.1 904 23.8
Current 9309 6.9 7448 6.5 1343 11.3 369 7.1 149 3.9
Alcohol b.001
Never 14,453 10.7 9985 8.8 2063 17.4 974 18.8 1431 37.6
Past 24,659 18.3 18,782 16.5 3911 32.9 1188 23.0 778 20.5
Current, b1 drink/d 79,744 59.1 70,097 61.4 5384 45.3 2775 53.6 1488 39.1
Current, 1+ drinks/d 16,080 11.9 15,219 13.3 518 4.4 237 4.6 106 2.8
Abbreviations: MI, myocardial infarction; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; BP, blood pressure.We calculated the AR for each of the preventable or
treatable risk factors for AF in each of the different
race-ethnic cohorts. The AR was calculated as the
difference between the rate of AF in the entire
racial-ethnic cohort minus the rate of AF in the
race-ethnic cohort without the risk factor, divided by
the rate of AF in the entire racial-ethnic cohort, multiplied
by 100.
The relationship between risk factors and incident AF
was examined using the multivariate Cox regression
models for each of the different race-ethnic groups.
Multivariate analyses were performed using a primary
model containing the following covariates with known or
suspected association with AF: age, education, BMI,
hypertension, diabetes, CAD, CHF, PAD smoking, andalcohol use. The associations between physical activity,
height, PR interval, and incident AF were assessed using a
multivariate Cox regression model adjusted for all
covariates in the primary regression model. All regression
models were additionally adjusted for time-dependent
exposure to Medicare coverage, as has been done in prior
analyses,16 as well as inclusion in a WHI randomized trial
and WHI intervention assignment. To determine if AF risk
conferred by the different risk factors differed across
different race-ethnic groups, we measured the interaction
between race/ethnicity and each of the covariates by
including a risk factor * race/ethnicity term in the primary
multivariate Cox regression model. Associations between
risk factors and AF were reported as hazard ratios (HRs)
with 95% CIs. The proportional hazards assumption was
Figure 1
Annualized rates of AF by age and race.verified by visual inspection of the log-likelihood plots of
developing AF over time.
Finally, the performance of the Framingham Heart Study
AF Score,28 Atherosclerosis Risk in Communities Study
(ARIC),29 and Women's Health Study (WHS)30 regression
models was tested at 5 and 10 years by estimating the c
statistic for thesemodels in eachof the different race-ethnic
cohorts. Because only the subset of women from the RCTs
had ECG data available, a c statistic was calculated both for
the full cohort without PR interval in the model, as well as
for the subgroup of women with ECG data (n = 50,428)
with the PR interval measurement.
Analyses were performed using SAS statistical software
(version 9.4; SAS Institute Inc, Cary, NC). The WHI
program is funded by the National Heart, Lung, and Blood
Institute, National Institutes of Health, US Department of
Health and Human Services through contracts
HHSN268201100046C, HHSN268201100001C,
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The authors are solely responsible for the design and
conduct of this study, all study analyses, the drafting and
editing of the manuscript, and its final contents.Results
Baseline characteristics
Of the 158,833 NHW, African American, Hispanic, and
Asian women enrolled in the WHI OS and RCTs, 6,926
were excluded because of baseline AF, 631 were
excluded for lack of follow-up, and 16,971 were excluded
due to missing covariate data of interest. There were a
total of 114,083 NHW, 11,876 African American, 5,174Hispanic, and 3,803 Asian women who met the inclusion
criteria. Baseline characteristics of the participants are
summarized in Table I. On average, women were 63.1
years of age, and most (78.1%) had some college
education or higher. African American and Hispanic
women were younger and had lower annual incomes.
More than 40% of Hispanic participants had a high school
education or less as compared with 21% of NHWwomen,
25% of African American women, and 21% of Asian
women (P b .001).
The prevalence of all traditional AF risk factors,
including hypertension, BMI, diabetes, CAD, CHF, and
PAD, differed across race-ethnic groups (analysis of
variance P b .001 for each risk factor, Table I). Notably,
almost two-thirds of the African American women in the
study had hypertension in contrast to only 41% of NHW
women. African American and Hispanic women had
higher BMIs and were more likely to have diabetes
compared with NHW women. Certain cardiovascular
diseases, including CAD, CHF, and PAD, were more
prevalent in African American women compared with
NHW women (Table I). Asian women had on average a
lower BMI than did NHW women (24.8 vs 27.6 kg/m2),
but higher rate of diabetes (5.8% vs 3.2%).
Risk factors for AF by race-ethnic subgroups
There were 18,090, 1,097, 295, and 233 incident AF
cases over an average of 13.7 years of follow-up among
NHW, African American, Hispanic, and Asian women,
respectively. The annualized rates of AF by age and race/
ethnicity are shown in Figure 1. Non-Hispanic white
women consistently had higher incidence of AF among all
age groups. Hispanic and Asian women had the lowest
rates of AF in all age groups. These differences were more
pronounced in the older age groups. There were a total of
3,895 incident atrial flutter cases during follow-up.
The impact of traditional and other AF risk factors
on AF incidence by race/ethnicity after multivariate
Figure 2
Multivariate-adjusted HRs of traditional and novel AF risk factors by race/ethnicity. 1HRs and interaction P values from a proportional hazards
model with the risk factor of interest, race/ethnicity, and their interaction, and are stratified within the model by WHI intervention arms, WHI
extension 2 membership, and time-dependent fee-for-service Medicare coverage. Models are additionally adjusted for education, pills for high
cholesterol, WHI intervention assignments, and all traditional risk factors in Table II.adjustment is shown in Figure 2. The hazards of AF due to
age were slightly higher in NHW and Asians, comparedwith
African Americans and Hispanics (HR for a 5-year increase
1.43, 1.40 vs 1.31 and 1.33, respectively;P interaction = .002).
Hazard ratios for the traditional risk factors of hypertension,
diabetes, BMI, and heart failure for incident AFwere similar
in NHW, African American, Hispanic, and Asian women.
Although the HRs for AF due to hypertension, CHF, and
CADwere higher in Hispanics comparedwith NHW, there
was no statistically significant interaction across all
race-ethnic groups. Alcohol use was associated with an
increased risk of AF to a greater degree in Asians compared
with NHW, African Americans, and Hispanics (HR 1.65 vs
1.04, 1.06, 1.06, respectively; P interaction = .02).
The multivariate-adjusted HRs of novel AF risk factors
by race/ethnicity are shown in Figure 2. Height was a
significant predictor of AF for all race-ethnic groups with
a higher predictive value among Hispanics and Asians
compared with NHW and African Americans (HR for
every 10-cm increase 1.53, 1.82 vs 1.28 and 1.27,
respectively; P interaction = .007).
Attributable risk
Table II demonstrates the ARs for reversible or treatable
AF risk factors by race/ethnicity. TheARdue to hypertension
was highest in the African American women (39.0%) andlowest in Asianwomen (18.3%).More than 83%of the AR for
African American women and 65.6% for Hispanic women
are accounted for by modifiable risk factors for AF, as
compared with just 50.3% for NHW women and 37.4% for
Asian women. Alcohol consumption was not included
because NHW, African American, and Hispanic women
who used alcohol had a lower rate of AF compared with
nonusers; however, alcohol accounted for 15% of the AR in
Asianwomen (data not shown), secondonly tohypertension
in that group.
Similarly, stroke accounted for a small fraction of the AR
for all populations: 0.8% for NHWs, 1.0% for African
Americans, 1.8% for Hispanics, and 1.7% for Asians.
Stroke was not included in Table II because it is not
generally considered a risk factor for AF since previously
unidentified silent forms of AF may account for some of
the strokes.
Atrial fibrillation prediction models
In the overall cohort, the Framingham, ARIC, and WHS
AF prediction models and the primary WHI regression
model used in this study performed similarly well in all
race-ethnic groups for both 5- and 10-year risk predictions
(c statistic 0.78-0.81) (Table III). Each of the models also
performed as well or slightly better in NHW race-ethnic
groups compared with the NHW group. In the WHI
Table II. Attributable risk (%) of traditional AF risk factors
Characteristic Level of interest NHW African American Hispanic Asian
Hypertension Yes 24.3 38.3 29.2 18.3
BMI N25 kg/m2 13.1 18.9 15.7 6.9
Diabetes Yes 2.6 8.7 3.6 4.9
Smoking Past/Current 4.3 5.4 9.1 4.2
PAD Yes 1.6 3.4 1.6 0.2
Heart failure Yes 0.9 2.9 2.0 1.1
Coronary heart disease Yes 3.5 5.5 4.4 1.8
Total 50.3 83.1 65.6 37.4regression model, the c statistics for 10-year prediction in
the Asian (0.87, 95% CI 0.83-0.90), Hispanic (0.85, 95% CI
0.82-0.87), and African American (0.83, 95% CI 0.82-0.85)
groups were higher than that in NHW (0.81, 95% CI
0.80-0.81), although the CIs overlap.
Discussion
In long-term follow-up of a large, diverse cohort of
postmenopausal women, we found that although minor-
ity women have a lower incidence of AF, many traditional
risk factors are more prevalent in some race-ethnic
cohorts, but individually contribute to AF risk to a similar
extent compared with NHWs. However, at the popula-
tion level, these risk factors contribute more to AF risk in
African Americans and Hispanics compared with NHW
and Asian counterparts. Importantly, particularly for
African American women, most of the AF risk may be
attributable to modifiable or treatable risk factors. We also
found that AF risk prediction models perform similarly
well in all race-ethnic groups.
The reasons for the observed racial and ethnic
differences in AF incidence and risk factors are not well
understood. Paradoxically, African Americans and His-
panics typically have higher rates of obesity, hyperten-
sion, and other cardiovascular risk factors, but a lower
rate of AF.1,31 Disparities in socioeconomic status and
lack of exposure to the health care system leading to
underreporting and ascertainment of AF in underrepre-
sented minority groups have been implicated for these
differences.32 However, the relationship between race
and AF persists after adjusting for a wide range of
socioeconomic and other risk factors, with African
Americans typically having a lower prevalence of
AF.33,34 This finding is seen even in veteran populations
with similar access to health care and in clinical
subgroups already receiving medical care, such as those
with heart failure.35 Atrial fibrillation is also detected at a
lower rate among African Americans who are constantly
monitored with implanted cardiac devices.36
One potential explanation for these racial-ethnic
disparities is a difference in genetic susceptibility to AF.
Although this may be true in younger populations,20 we
did not find this to be the case in the admixture study ofthe WHI SHARe African American cohort, which
included older women.21 This suggests that, at least in
older women, clinical and environmental factors are
more likely to account for the observed differences. We
found that, particularly among African Americans, most
of the attributable risk of AF can be explained by traditional,
reversible factors. Similarly, findings from the Southern
Community Cohort Study reported that hypertension and
diabetes were stronger AF risk factors (as measured by
HRs) in African Americans.37 More recently, findings from
the Multiethnic Study of Atherosclerosis also showed that
hypertension explained more of the population risk for AF
among nonwhite participants.38
To explain the lower rates of AF in minority race-ethnic
groups despite higher rates of traditional risk factors, we
hypothesized that the hazards attributed to some of the
traditional risk factors might be lower. However, we
found that for the traditional cardiovascular risk factors
except for age, the hazards were similar. It is possible that
there are additional and important unmeasured environ-
mental risks or other biologic factors that increase the risk
of AF in NHWs or protect from AF in minority groups.
Deeper characterization of risk factors will need to be
performed in individual subgroups to identify these
important, yet unidentified, characteristics.
Although the hazard from alcohol use was much higher
in Asians compared with other race-ethnic groups, the P
for interaction was not significant after adjusting for
multiple hypothesis testing. Nevertheless, if this finding
can be validated in other cohorts, it may suggest that
alcohol metabolites, which are higher in Asians who
consume alcohol,39 might contribute significantly to AF
risk. Mendelian randomization studies of variants in the
alcohol dehydrogenase and acetaldehyde dehydrogenase
genes may also be revealing.
Although existing AF prediction models perform well
in African Americans,29,40 they have not been validated in
other racial-ethnic cohorts. We found that the different
commonly used AF predictive models perform equally
well, if not better, among nonwhite women. This may be
in part because the traditional risk factors included in
these models account for a large proportion of the AR for
AF among these groups.
Table III. Performance of different AF prediction models as measured by c statistics with 95% CIs for each race-ethnic group at 5 and 10 years
Time Race/Ethnicity Model 1 Model 2 Model 3a
5 y All 0.80 (0.79, 0.80) 0.80 (0.79, 0.80) 0.79 (0.78, 0.79)
NHW 0.79 (0.79, 0.80) 0.80 (0.79, 0.80) 0.79 (0.78, 0.79)
African American 0.82 (0.79, 0.84) 0.82 (0.80, 0.85) 0.81 (0.79, 0.83)
Hispanic 0.82 (0.77, 0.86) 0.82 (0.77, 0.87) 0.81 (0.76, 0.86)
Asian 0.82 (0.78, 0.87) 0.84 (0.80, 0.88) 0.81 (0.77, 0.86)
10 y All 0.81 (0.80, 0.81) 0.81 (0.81, 0.82) 0.81 (0.80, 0.81)
NHW 0.81 (0.80, 0.81) 0.81 (0.80, 0.81) 0.80 (0.80, 0.81)
African American 0.83 (0.82, 0.85) 0.84 (0.82, 0.85) 0.83 (0.81, 0.85)
Hispanic 0.85 (0.82, 0.87) 0.85 (0.82, 0.87) 0.84 (0.81, 0.87)
Asian 0.87 (0.83, 0.90) 0.87 (0.84, 0.90) 0.85 (0.82, 0.89)
Time Race/Ethnicity Model 3b Model 4 Model 5
5 y All 0.79 (0.78, 0.80) 0.80 (0.79, 0.80) 0.78 (0.77, 0.78)
NHW 0.79 (0.78, 0.80) 0.79 (0.79, 0.80) 0.77 (0.77, 0.78)
African American 0.79 (0.75, 0.83) 0.81 (0.79, 0.84) 0.79 (0.77, 0.82)
Hispanic 0.81 (0.73, 0.89) 0.80 (0.76, 0.85) 0.78 (0.73, 0.83)
Asian 0.87 (0.80, 0.94) 0.82 (0.78, 0.87) 0.82 (0.77, 0.86)
10 y All 0.79 (0.79, 0.80) 0.81 (0.81, 0.82) 0.80 (0.80, 0.81)
NHW 0.79 (0.79, 0.80) 0.81 (0.80, 0.81) 0.80 (0.79, 0.80)
African American 0.79 (0.76, 0.82) 0.83 (0.82, 0.85) 0.82 (0.80, 0.84)
Hispanic 0.79 (0.74, 0.84) 0.84 (0.81, 0.87) 0.83 (0.80, 0.86)
Asian 0.82 (0.75, 0.88) 0.86 (0.82, 0.89) 0.85 (0.82, 0.89)
Model 1: primary model—age, educational status, BMI, hypertension, diabetes, hyperlipidemia, CAD, CHF, PAD, smoking, alcohol use. Model 2: primary model + physical activity,
height. Model 3a: reduced Framingham model, does not include PR interval component. Model 3b: full Framingham model, ECG participants only (n = 50,428). Model 4: ARIC.29
Model 5: WHS.30
All WHI models are additionally adjusted for any fee-for-service CMS coverage during follow-up (yes/no) as well as for WHI intervention assignments.This study has several strengths including the large size
and ethnic diversity in WHI and the deep characterization
of the participants, which offers a unique opportunity to
study the makeup of AF risk in different racial and ethnic
cohorts. Potential limitations include errors in AF
ascertainment by the use of ICD-9 codes, although the
use of ICD-9 codes to identify incident AF has been
validated in several large population studies,2,10,17
including the WHI.16 Because of the small number of
incident atrial flutter cases, the study focused on incident
AF but misclassification remains possible. For women
with asymptomatic, paroxysmal AF, AF may be missed,
resulting in misclassification, although this bias would be
nondifferential by race and ethnicity and is a limitation in
most long-term population studies that could only be
overcome by continuous monitoring in the future.
Finally, generalizability is limited because the study was
conducted in postmenopausal women.
Conclusions
We found that although the incidence of AF is lower in
minority groups, traditional risk factors account for a
larger proportion of the AF burden in these groups.
In addition, commonly used AF prediction models
perform equally well and sometimes better in nonwhite
groups. Future studies should explore novel genetic andenvironmental factors that explain the variance in AF risk
among diverse populations.Acknowledgements
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